National outcomes following benign cardiac tumor resection: A critical sex‐based disparity. Issue 9 (3rd June 2022)

• Record Type: Journal Article
• Authors: Newell, Paige; Zogg, Cheryl K.; Kusner, Jonathan; Hirji, Sameer; Kerolos, Mariam; Kaneko, Tsuyoshi
• Is Part Of: Journal of cardiac surgery. Volume 37:Issue 9(2022)
• Page Start: 2653
• Page End: 2660
• Publication Date: 2022-06-03
• Subjects: benign cardiac tumor -- cardiac tumor excision -- gender disparities; Heart -- Surgery -- Periodicals; 617.412005
• DOI: 10.1111/jocs.16654
• Languages: English
• ISSNs: 0886-0440

Abstract

Abstract: Background: Treatment of benign primary cardiac tumors involves surgical resection, but reported outcomes from multi‐institutional or national databases are scarce. This study examines contemporary national outcomes following surgical resection of benign primary atrial and ventricular tumors. Methods: The 2016–2018 Nationwide Readmissions Database was queried for all patients ≥18 years with a primary diagnosis of benign neoplasm of the heart who underwent resection of the atria, ventricles, or atrial/ventricular septum. Primary outcomes were 30‐day mortality, readmission, and composite morbidity (defined as stroke, permanent pacemaker implantation, bleeding complication, or acute kidney injury). Multivariable analysis was used to identify independent predictors of worse outcomes. Results: A weighted total of 2557 patients met inclusion criteria. Mean age was 61 years, 67.9% were female, and patients had relatively low comorbidity burdens (mean Charlson Comorbidity Index 1.39). The majority of patients underwent excision of the left atrium (71.5%), followed by the intra‐atrial septum (26.6%), right atrium (2.9%). There was no difference in 30‐day mortality (2.1% vs. 1.3%, p = .550), 30‐day readmission (7.0% vs. 9.1%, p = .222), or 30‐day composite morbidity (56.8% vs. 53.8%, p = .369) between females and males, respectively. However, on multivariable analysis, female sex was independently associated with increased risk of 30‐day mortality (adjusted odds ratio = 2.65, p = .028). Tumor location (atria, ventricles, septum) was not predictive of mortality. Conclusion: Benign atrial and ventricular tumors are uncommon, but disproportionately impact female patients, with female sex being an independent predictor of 30‐day mortality. Root‐cause analysis is necessary to determine the ultimate cause of this disparity.